Suppr超能文献

溶栓后无症状性出血可能并非良性:加拿大阿替普酶治疗卒中有效性研究登记中按出血类型的预后情况

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.

作者信息

Dzialowski Imanuel, Pexman J H Warwick, Barber Philip A, Demchuk Andrew M, Buchan Alastair M, Hill Michael D

机构信息

Calgary Stroke Program, Department of Clinical Neurosciences, Foothills Hospital, 1403 29th St NW, Calgary, Alberta, Canada.

出版信息

Stroke. 2007 Jan;38(1):75-9. doi: 10.1161/01.STR.0000251644.76546.62. Epub 2006 Nov 22.

Abstract

BACKGROUND AND PURPOSE

There is ongoing controversy about the impact of hemorrhagic transformation after thrombolysis on long-term functional outcome. We sought to study the relation between the type of hemorrhagic transformation on CT scans and functional outcome.

METHODS

Data were obtained from the Canadian Alteplase for Stroke Effectiveness Study. This study was established as a registry to prospectively collect data for acute stroke patients receiving intravenous alteplase within 3 hours from stroke onset between February 1999 and June 2001. Follow-up was completed at 90 days, and good functional outcome was defined as a modified Rankin Scale score of 0 or 1. Copies of head CT scans obtained at 24 to 48 hours after starting treatment were read in consensus by a central reading panel consisting of 1 neuroradiologist and 1 stroke neurologist. According to European Cooperative Acute Stroke Study criteria, hemorrhagic transformation was classified as none, hemorrhagic infarction (HI-1 and HI-2), or parenchymal hematoma (PH-1 and PH-2). We compared outcome across groups and performed a multivariable analysis including previously determined important predictors of good outcome in acute ischemic stroke.

RESULTS

From 1135 patients enrolled at 60 centers across Canada, 954 follow-up CT scans were assessable. We observed some hemorrhagic transformation in 259 of 954 (27.1%) patients (110 HI-1, 57 HI-2, 48 PH-1, and 44 PH-2). Proportions of patients with good outcome were 41% with no hemorrhagic transformation, 30% with HI-1, 17% with HI-2, 15% with PH-1, and 7% with PH-2 (P<0.0001, chi(2) test). After adjustment for age, baseline serum glucose, baseline Alberta Stroke Program Early CT score, and baseline National Institutes of Health Stroke Scale score, HI-1 was not a predictor of outcome. However, HI-2 (odds ratio=0.38, 95% CI=0.17 to 0.83), PH-1 (odds ratio=0.32, 95% CI=0.12 to 0.80), and PH-2 (odds ratio=0.14, 95% CI=0.04 to 0.48) were all negative predictors of outcome.

CONCLUSIONS

The likelihood of a poor outcome after thrombolysis was proportional to the extent of hemorrhage on CT scans. HI grades of hemorrhagic transformation may not be benign.

摘要

背景与目的

溶栓后出血转化对长期功能结局的影响一直存在争议。我们试图研究CT扫描上出血转化类型与功能结局之间的关系。

方法

数据来自加拿大急性缺血性脑卒中阿替普酶疗效研究。该研究作为一个登记处,前瞻性收集1999年2月至2001年6月期间在卒中发作3小时内接受静脉阿替普酶治疗的急性卒中患者的数据。随访在90天时完成,良好的功能结局定义为改良Rankin量表评分为0或1。由1名神经放射科医生和1名卒中神经科医生组成的中央阅片小组对治疗开始后24至48小时获得的头部CT扫描副本进行了一致阅片。根据欧洲急性卒中协作研究标准,出血转化分为无、出血性梗死(HI-1和HI-2)或实质内血肿(PH-1和PH-2)。我们比较了各组的结局,并进行了多变量分析,包括先前确定的急性缺血性卒中良好结局的重要预测因素。

结果

在加拿大60个中心登记的1135例患者中,954份随访CT扫描可进行评估。在954例患者中的259例(27.1%)观察到一些出血转化(110例HI-1,57例HI-2,48例PH-1和44例PH-2)。无出血转化患者的良好结局比例为41%,HI-1患者为30%,HI-2患者为17%,PH-1患者为15%,PH-2患者为7%(P<0.0001,卡方检验)。在调整年龄、基线血清葡萄糖、基线阿尔伯塔卒中项目早期CT评分和基线美国国立卫生研究院卒中量表评分后,HI-1不是结局的预测因素。然而,HI-2(比值比=0.38,95%CI=0.17至0.83)、PH-1(比值比=0.32,95%CI=0.12至0.80)和PH-2(比值比=0.14,95%CI=0.04至0.48)均为结局的负性预测因素。结论:溶栓后不良结局的可能性与CT扫描上的出血程度成正比。出血转化的HI分级可能并非良性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验